2024, Hiramatsu K, Maeda H. Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review. Clin Transl Sci. 2024 May;17(5):e13794. doi: 10.1111/cts.13794.
業績
2024, Hiramatsu K, Maeda H. Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review. Clin Transl Sci. 2024 May;17(5):e13794. doi: 10.1111/cts.13794.